Riskpilot← Back to searchSign inGet full accessMAGE- TARMKLINIKKEN AS
ASActiveOrg 913131592Vestre Gate 1, 4836 ArendalMedical specialists activities · NACE 8622Est. 20144 employees
Revenue 2024
NOK 6,7M
+2% vs 2023
EBITDA margin
47.8%
+6% vs 2023
Equity ratio
26.3%
Financial strength
Net profit 2024
NOK 2,4M
+7% vs 2023
| Revenue | NOK 6,7M | +2% |
| EBITDA | NOK 3,2M | +6% |
| Net profit | NOK 2,4M | +7% |
| Total assets | NOK 3,9M | +10% |
| Equity | NOK 1M | +160% |
| Employees | 4 | — |
Legal name
MAGE- TARMKLINIKKEN AS
Org number
913131592
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
28. januar 2014
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Helsevirksomhet med utgangspunkt i privat praksis i fordøyelsessykdommer med refusjonsrett, samt annet som står i forbindelse med dette, herunder deltakelse i andre selskap.
Address
Vestre Gate 1, 4836 Arendal
Phone
+4737020083
Email
einar.beitohaugen@mtk.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 845 | 6 017 | 6 199 | 6 607 | 6 731 |
| Staff expenses | −1 576 | −1 606 | −1 625 | −1 818 | −1 787 |
| EBITDA | 2 935 | 2 913 | 3 105 | 3 030 | 3 214 |
| Depreciation & amort. | −163 | −155 | −147 | −140 | −166 |
| EBIT | 2 772 | 2 757 | 2 958 | 2 890 | 3 048 |
| Net financials | 9 | 7 | −1 998 | 35 | 89 |
| Profit before tax | 2 781 | 2 764 | 960 | 2 925 | 3 137 |
| Tax | 613 | 610 | 653 | 644 | 703 |
| Net profit | 2 168 | 2 154 | 308 | 2 281 | 2 434 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 247 | 3 229 | 2 576 | 3 583 | 3 930 |
| Equity | 2 355 | 1 209 | 117 | 398 | 1 032 |
| Long-term debt | 64 | 43 | 31 | 13 | 0 |
| Short-term debt | 1 828 | 1 977 | 2 428 | 3 172 | 2 898 |
| Total debt | 1 892 | 2 020 | 2 459 | 3 185 | 2 898 |
EBITDA margin
47.8%
This company
15.8%
Market median
+203% vs market
20202024
Equity ratio
26.3%
This company
38.2%
Market median
-31% vs market
20202024
Return on equity
235.9%
This company
18.4%
Market median
+1182% vs market
20202024
Net profit margin
36.2%
This company
8.1%
Market median
+347% vs market
20202024
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20202024
Debt / equity
2.81×
This company
0.62×
Market median
-353% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2014 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MAGE- TARMKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Einar Beitohaugen | Chief Executive Officer | 0 companies |